[{"id":"5b7ed973-4ac5-4c9d-8a94-360ea8f63cab","acronym":"","url":"https://clinicaltrials.gov/study/NCT05106946","created_at":"2021-11-04T16:57:12.845Z","updated_at":"2024-07-02T16:36:20.869Z","phase":"Phase 1","brief_title":"Safety and Clinical Activity of ThisCART22 in Patients With r/r Non-Hodgkin's B Cell Lymphoma","source_id_and_acronym":"NCT05106946","lead_sponsor":"Fundamenta Therapeutics, Ltd.","biomarkers":" CD22","pipe":"","alterations":" ","tags":["CD22"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ThisCART22"],"overall_status":"Recruiting","enrollment":" Enrollment 20","initiation":"Initiation: 10/25/2021","start_date":" 10/25/2021","primary_txt":" Primary completion: 10/25/2023","primary_completion_date":" 10/25/2023","study_txt":" Completion: 10/25/2024","study_completion_date":" 10/25/2024","last_update_posted":"2021-11-11"}]